160 related articles for article (PubMed ID: 11241317)
1. Altered DNA repair capacity and bleomycin sensitivity as risk markers for non-small cell lung cancer.
Rajaee-Behbahani N; Schmezer P; Risch A; Rittgen W; Kayser KW; Dienemann H; Schulz V; Drings P; Thiel S; Bartsch H
Int J Cancer; 2001 Mar; 95(2):86-91. PubMed ID: 11241317
[TBL] [Abstract][Full Text] [Related]
2. Rapid screening assay for mutagen sensitivity and DNA repair capacity in human peripheral blood lymphocytes.
Schmezer P; Rajaee-Behbahani N; Risch A; Thiel S; Rittgen W; Drings P; Dienemann H; Kayser KW; Schulz V; Bartsch H
Mutagenesis; 2001 Jan; 16(1):25-30. PubMed ID: 11139596
[TBL] [Abstract][Full Text] [Related]
3. Gamma-radiation-induced single cell DNA damage as a measure of susceptibility to lung cancer: a preliminary report.
Zhang H; Buchholz TA; Hancock D; Spitz MR; Wu X
Int J Oncol; 2000 Aug; 17(2):399-404. PubMed ID: 10891553
[TBL] [Abstract][Full Text] [Related]
4. Rapid method for determination of DNA repair capacity in human peripheral blood lymphocytes amongst smokers.
El-Zein RA; Monroy CM; Cortes A; Spitz MR; Greisinger A; Etzel CJ
BMC Cancer; 2010 Aug; 10():439. PubMed ID: 20718982
[TBL] [Abstract][Full Text] [Related]
5. Reduced DNA repair capacity in lung cancer patients.
Wei Q; Cheng L; Hong WK; Spitz MR
Cancer Res; 1996 Sep; 56(18):4103-7. PubMed ID: 8797573
[TBL] [Abstract][Full Text] [Related]
6. Prospective analysis of DNA damage and repair markers of lung cancer risk from the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial.
Sigurdson AJ; Jones IM; Wei Q; Wu X; Spitz MR; Stram DA; Gross MD; Huang WY; Wang LE; Gu J; Thomas CB; Reding DJ; Hayes RB; Caporaso NE
Carcinogenesis; 2011 Jan; 32(1):69-73. PubMed ID: 20929901
[TBL] [Abstract][Full Text] [Related]
7. Bleomycin-induced DNA damage and its removal in lymphocytes of breast cancer patients studied by comet assay.
Jałoszyński P; Kujawski M; Czub-Swierczek M; Markowska J; Szyfter K
Mutat Res; 1997 Dec; 385(3):223-33. PubMed ID: 9506891
[TBL] [Abstract][Full Text] [Related]
8. In vitro benzo[a]pyrene diol epoxide-induced DNA damage and chromosomal aberrations in primary lymphocytes, smoking, and risk of squamous cell carcinoma of the head and neck.
Xiong P; Hu Z; Li C; Wang LE; El-Naggar AK; Sturgis EM; Wei Q
Int J Cancer; 2007 Dec; 121(12):2735-40. PubMed ID: 17724733
[TBL] [Abstract][Full Text] [Related]
9. DNA crosslinks, DNA damage and repair in peripheral blood lymphocytes of non-small cell lung cancer patients treated with platinum derivatives.
Fikrova P; Stetina R; Hrnciarik M; Hrnciarikova D; Hronek M; Zadak Z
Oncol Rep; 2014 Jan; 31(1):391-6. PubMed ID: 24154806
[TBL] [Abstract][Full Text] [Related]
10. High mutagen sensitivity in peripheral blood lymphocytes predicts poor overall and disease-specific survival in patients with stage III non-small cell lung cancer treated with radiotherapy and chemotherapy.
Chang JY; Komaki R; Sasaki R; Liao Z; Stevens CW; Lu C; Fossella FV; Allen PK; Cox JD; Spitz MR; Wu X
Clin Cancer Res; 2005 Apr; 11(8):2894-8. PubMed ID: 15837739
[TBL] [Abstract][Full Text] [Related]
11. Sensitivity to NNKOAc is associated with renal cancer risk.
Clague J; Shao L; Lin J; Chang S; Zhu Y; Wang W; Wood CG; Wu X
Carcinogenesis; 2009 Apr; 30(4):706-10. PubMed ID: 19237609
[TBL] [Abstract][Full Text] [Related]
12. Ionizing radiation-induced γ-H2AX activity in whole blood culture and the risk of lung cancer.
He Y; Gong Y; Lin J; Chang DW; Gu J; Roth JA; Wu X
Cancer Epidemiol Biomarkers Prev; 2013 Mar; 22(3):443-51. PubMed ID: 23300022
[TBL] [Abstract][Full Text] [Related]
13. Detecting DNA repair capacity of peripheral lymphocytes from cancer patients with UVC challenge test and bleomycin challenge test.
Wei Z; Lifen J; Jiliang H; Jianlin L; Baohong W; Hongping D
Mutagenesis; 2005 Jul; 20(4):271-7. PubMed ID: 15899932
[TBL] [Abstract][Full Text] [Related]
14. Bleomycin-induced chromosome breaks as a risk marker for lung cancer: a case-control study with population and hospital controls.
Zheng YL; Loffredo CA; Yu Z; Jones RT; Krasna MJ; Alberg AJ; Yung R; Perlmutter D; Enewold L; Harris CC; Shields PG
Carcinogenesis; 2003 Feb; 24(2):269-74. PubMed ID: 12584177
[TBL] [Abstract][Full Text] [Related]
15. Suppression of a DNA base excision repair gene, hOGG1, increases bleomycin sensitivity of human lung cancer cell line.
Wu M; Zhang Z; Che W
Toxicol Appl Pharmacol; 2008 May; 228(3):395-402. PubMed ID: 18234257
[TBL] [Abstract][Full Text] [Related]
16. DNA repair deficiency in peripheral blood lymphocytes of endometrial cancer patients with a family history of cancer.
Buchynska L; Brieieva O; Glushchenko N; Vorobyova L; Bilyk O
BMC Cancer; 2014 Oct; 14():765. PubMed ID: 25315979
[TBL] [Abstract][Full Text] [Related]
17. Smoking, DNA repair capacity and risk of nonsmall cell lung cancer.
Shen H; Spitz MR; Qiao Y; Guo Z; Wang LE; Bosken CH; Amos CI; Wei Q
Int J Cancer; 2003 Oct; 107(1):84-8. PubMed ID: 12925960
[TBL] [Abstract][Full Text] [Related]
18. DNA repair activity for oxidative damage and risk of lung cancer.
Paz-Elizur T; Krupsky M; Blumenstein S; Elinger D; Schechtman E; Livneh Z
J Natl Cancer Inst; 2003 Sep; 95(17):1312-9. PubMed ID: 12953085
[TBL] [Abstract][Full Text] [Related]
19. DNA damage and breast cancer risk.
Smith TR; Miller MS; Lohman KK; Case LD; Hu JJ
Carcinogenesis; 2003 May; 24(5):883-9. PubMed ID: 12771032
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of in vitro genotoxic activity of bleomycin and mitomycin C in human lymphocytes using the alkaline comet assay.
Milić M; Kopjar N
Arh Hig Rada Toksikol; 2004 Nov; 55(4):249-59. PubMed ID: 15584551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
